Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression: the ASSURE study

Attention deficit-hyperactivity disorder (ADHD) is related to depressive disorder, and adolescents with both present poor outcomes. However, evidence for the safety of concomitantly using a methylphenidate (MPH) and a selective serotonin reuptake inhibitor (SSRI) among adolescent ADHD patients is li...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychological medicine 2023-07, Vol.53 (10), p.4811-4819
Hauptverfasser:	Kim, Chungsoo, Lee, Dong Yun, Park, Jimyung, Yang, Su-Jin, Tan, Eng Hooi, Prieto-Alhambra, Daniel, Lee, Yo Han, Lee, Sangha, Kim, Seong-Ju, Lee, Jeewon, Park, Rae Woong, Shin, Yunmi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjustment Adolescent Adolescents Antidepressants Attention Deficit Disorder with Hyperactivity - drug therapy Attention Deficit Disorder with Hyperactivity - epidemiology Attention Deficit Disorder with Hyperactivity - psychology Attention deficit hyperactivity disorder Central Nervous System Stimulants - adverse effects Citalopram Cohort analysis Cohort Studies Comorbidity Depression - drug therapy Depression - epidemiology Depressive personality disorders Epidemiology Escitalopram Fluoxetine Fluoxetine - adverse effects Hospitalization Humans Mental depression Methylphenidate Methylphenidate - adverse effects Original Article Population Population studies Propensity Respiratory diseases Respiratory tract diseases Respiratory tract infections Safety Selective Serotonin Reuptake Inhibitors - adverse effects Sensitivity analysis Serotonin Serotonin reuptake inhibitors Serotonin uptake inhibitors Suicidal behavior Suicides & suicide attempts Teenagers Tic Disorders Tics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!